Development of Technologies to Facilitate the Use of and Response to Vaccines

Information

  • Research Project
  • 8164633
  • ApplicationId
    8164633
  • Core Project Number
    272201000034C-0-0-1
  • Full Project Number
    272201000034C-0-0-1
  • Serial Number
    0
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/31/2010 - 14 years ago
  • Project End Date
    8/30/2015 - 9 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2010
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

Development of Technologies to Facilitate the Use of and Response to Vaccines

This contract supports the advanced development of candidate products, comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. Such technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    N01
  • Administering IC
    AI
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1833080
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:1833080\
  • Funding Mechanism
    Contracts, Extramural
  • Study Section
  • Study Section Name
  • Organization Name
    INVIRAGEN, INC.
  • Organization Department
  • Organization DUNS
    141588801
  • Organization City
    FORT COLLINS
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    805259769
  • Organization District
    UNITED STATES